BDBM97473 US8470816, 21

SMILES COc1ccc(cc1)C(=O)N(C)[C@@H]1CCN(CC1c1ccc(Cl)c(Cl)c1)C(=O)C1CCN(CC1)C(C)=O

InChI Key InChIKey=OAVNGCZBHRXUGH-ANWICMFUSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 97473   

TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50:  330nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50:  130nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50:  2.30nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent